This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Bausch Health Ireland Limited, Bausch-Lomb Incorporated. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: The Innovative Contributions of Daniel J Stein
Introduction
Daniel J Stein is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of suspensions of low-solubility materials. His work has implications for improving the delivery of active pharmaceutical ingredients (APIs) in various medical applications.
Latest Patents
Daniel J Stein holds a patent for a method that enhances the preparation of pharmaceutical suspensions. The patent, titled "Method for preparing suspensions of low-solubility materials," outlines a process that involves creating a first solution with a carboxy-containing vinyl polymer and a solvent. The process includes adding a compound of the API to this solution under high-shear mixing conditions, resulting in a suspension with a higher concentration of the API than its solubility in the solvent. This innovative approach addresses challenges in pharmaceutical formulations and enhances the efficacy of medications.
Career Highlights
Stein is associated with Bausch + Lomb Incorporated, a leading company in the eye health sector. His work at Bausch + Lomb has allowed him to focus on developing solutions that improve patient outcomes through innovative pharmaceutical formulations. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in the field.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues such as James Donald Hayes and Steven K MacLeod. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Daniel J Stein's contributions to the pharmaceutical industry exemplify the importance of innovation in developing effective medical solutions. His patented methods for preparing suspensions of low-solubility materials represent a significant advancement in pharmaceutical technology.
